UAB 1395 - Randomized Phase II Screening Trial of Enzalutamide/MDV-3100 and LHRH Analogue vs Combined Androgen Deprivation (LHRH Analogue + Bicalutamide) in Metastatic Hormone Sensitive Prostate Cancer

Grant

Date/time Interval

  • September 28, 2019 - August 25, 2021

    • Awarded By

    Total Award Amount

  • 0.00

    • Direct Costs

  • 0.00

    • Sponsor Award Id

    • Contributor

  • Lakshminarayanan Nandagopal   Principal Investigator  
  • Mollie Deshazo M.D.   Investigator